BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8681013)

  • 1. Evaluating the benefits of nuclear cardiology.
    Maisey M
    Q J Nucl Med; 1996 Mar; 40(1):47-54. PubMed ID: 8681013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic outcomes assessment in nuclear cardiology.
    Shaw LJ; Miller DD; Berman DS; Hachamovitch R
    Q J Nucl Med; 2000 Jun; 44(2):138-52. PubMed ID: 10967624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes assessment and disease management strategies in diagnostic imaging: creating value and quality with nuclear cardiology.
    Shaw LJ; Hachamovitch R; Thomas G
    J Cardiovasc Manag; 1998; 9(5):10-8. PubMed ID: 10185107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear cardiology in hospital-based practice.
    Gibbons R
    J Nucl Cardiol; 1997; 4(2 Pt 2):S179-83. PubMed ID: 9115082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies.
    Gazelle GS; McMahon PM; Siebert U; Beinfeld MT
    Radiology; 2005 May; 235(2):361-70. PubMed ID: 15858079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost efficiency of nuclear cardiology services in the modern health care environment.
    Miller DD
    Curr Cardiol Rep; 2004 Jan; 6(1):41-52. PubMed ID: 14662097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I.
    Shaw LJ; Hachamovitch R; Eisenstein EL; Kesler KL; Heller GV; Miller DD
    J Nucl Cardiol; 1996; 3(6 Pt 1):538-45. PubMed ID: 8989677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness.
    Pickett K; Loveman E; Kalita N; Frampton GK; Jones J
    Health Technol Assess; 2015 Oct; 19(86):1-176, v-vi. PubMed ID: 26502807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2009 ASNC keynote lecture: measuring cost, cost-effectiveness, and quality in cardiovascular imaging.
    Bonow RO
    J Nucl Cardiol; 2010 Jun; 17(3):362-9. PubMed ID: 20339963
    [No Abstract]   [Full Text] [Related]  

  • 14. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications.
    Shaw LJ
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I39-48. PubMed ID: 9383601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
    Willems P
    Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II.
    Shaw LJ; Eisenstein EL; Hachamovitch R; Heller GV; Miller DD
    J Nucl Cardiol; 1997; 4(1 Pt 1):52-60. PubMed ID: 9138840
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of nuclear cardiology.
    Maddahi J; Iskandrian AE
    J Nucl Cardiol; 1997; 4(2 Pt 2):S139-40. PubMed ID: 9115075
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methods and clinical applications in nuclear cardiology: a position statement].
    Schäfers M
    Nuklearmedizin; 2002 Feb; 41(1):3-13. PubMed ID: 11917345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear cardiology in private practice.
    Bateman TM
    J Nucl Cardiol; 1997; 4(2 Pt 2):S184-8. PubMed ID: 9115083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.